Stay updated on Nivolumab for Cervical Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for Cervical Cancer Clinical Trial page.

Latest updates to the Nivolumab for Cervical Cancer Clinical Trial page
- Check5 days agoChange DetectedCreighton University Medical Center in Omaha, Nebraska was removed; UT MD Anderson Cancer Center was added, and the total number of study locations was updated from 333 to 332.SummaryDifference0.1%

- Check12 days agoChange DetectedThe study page now shows that enrollment has closed ('No longer looking for participants'), and new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) are added alongside a revision note for v3.6.0.SummaryDifference0.1%

- Check20 days agoChange DetectedThe page now lists Revision: v3.5.5, replacing Revision: v3.5.4 in the footer. This indicates a minor administrative update to the study record that does not modify core content or outcomes.SummaryDifference0.0%

- Check27 days agoChange DetectedA new site, Saint Joseph Medical Center Hematology and Oncology - Silverdale, was added to the study locations, and Saint Michael Cancer Center was removed from the list of participating sites.SummaryDifference0.1%

- Check41 days agoChange DetectedThe revision label on the page changed from v3.5.3 to v3.5.4, signaling a deployment of updates to the page. This appears to be a minor, non-content change affecting the page's presentation or underlying functionality rather than the study data.SummaryDifference0.0%

- Check55 days agoChange DetectedAdded date entries: 2026-04-29, 2027-03-30, 2026-04-09, and 2026-03; removed entries: 2025-09-08, 2026-03-17, 2025-09-05, and 2025-09. These reflect updates to the study record timelines (latest updates, study completion, and verification) and removal of outdated milestones.SummaryDifference0.1%

Stay in the know with updates to Nivolumab for Cervical Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for Cervical Cancer Clinical Trial page.